Monday, 1 April 2019

Combination Immunotherapy to Treat Rare, Aggressive Neuroendocrine Cancer

Combination of Ipilimumab and nivolumab found effective in treating high grade aggressive, rare nueroendocrine cancer.


from Medindia Health News https://ift.tt/2YEFpot

No comments:

Post a Comment